CORT Q1 2017 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$28M+71.8% YoY

Gross Profit

$27M97.7% margin

Operating Income

$5M17.2% margin

Net Income

$4M15.9% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

+15.9%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$9M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$75M

Total Liabilities

$26M

Stockholders' Equity

$50M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$16M	+71.8%
Gross Profit	$27M	$16M	+72.1%
Operating Income	$5M	$592,000	+700.7%
Net Income	$4M	-$19,000	+23194.7%